followers view all
|healthcareproduct is not in any groups|
children with cancer the right to test new drugs
Children with cancer have access to potentially lifesaving drugs, because European Union rules allow pharmaceutical companies to overlook the need for control of certain drugs in pediatric trials, reports Reuters citing statements by researchers. Telemarketing call for closing this gap in legislation EU scientists and experts in child oncology, under the leadership of the British Institute for Cancer
Research (ICR), said that the change of these rules could save the lives of many children. "Several drugs have been developed for adults to combat cancer, could be effective in children, something that is necessary to make clinical trials, "he told reporters during a press conference Kresler Lewis, a researcher at ICR at the Royal Marsden
hospital London. Currently, pharmaceutical companies developing new cancer drugs are exempt from making accurate tests in patients under 18 years, even when the mechanism of action of these drugs probably prove effective in children. http://fortalent.com/blog/view/s/2014-05-15-acne-no-more-program-mike-walden-scam-review-program/
As a result, experts say simaionontai long delays in the availability of new drugs, some of them never approved for use in minors. "Children wronged in many areas of life," said Kresler. "But drugs for cancer should not be part of this injustice."
'This system fails to provide children with access to new treatments that could add years to their lives, "said Alan Asgouorth, CEO ICR. "I do not blame the EU legislation for this - the system should be modernized but directly," he added. Based on surveys conducted by the ICR in collaboration with the European
Consortium for Innovative Therapies for Children with Cancer (ITCC), found that 28 cancer drugs approved for use in adults in Europe since 2007, the 26 operating in a way that is relevant for childhood cancer.
However, 14 of these have been excluded from being tested in children, because the conditions of cancer which have developed drugs do not occur in children. The ICR and other international research centers that deal with cancer treatment
, seek the EU to abolish the right of pharmaceutical companies to exclude trials, which would force them to consider the possibility of a drug in both adults and children.
|share||like 2||report||68 views|